SkyQuest Technology Group has recently published a comprehensive Animal Vaccines Market report, offering a detailed analysis of the product landscape and industry scope while providing insights into the market outlook and future trends from 2025 to 2032. Increased outbreaks of animal disease and an ever-increasing livestock population are the primary reasons for the wider acceptance of ruminant vaccines, particularly cattle vaccines, around the world. Meat, protein, food, milk, and other commercial products such as wool and leather are all obtained from animals. Rabies vaccines, equine influenza virus vaccines, and foot and mouth disease vaccines are the most commonly used animal vaccines, which prevent the transmission of infectious agents by mimicking naturally immune defense.
Animal Vaccines Market size was valued at USD 12.8 Billion in 2023 and is poised to grow from USD 14 Billion in 2024 to USD 28.58 Billion by 2032, growing at a CAGR of 9.4% during the forecast period (2025-2032).
Growing concerns about food security, as well as increased animal husbandry, are driving up demand for livestock vaccines. Globally, increased demand for animal products has resulted in increased livestock production. Moreover, various factors such as changing food preferences as a result of changing lifestyles and population growth are driving up demand for livestock products. These factors are assisting the Animal Vaccines Market expansion. The constant introduction of technologically advanced vaccines, as well as the outbreak of livestock diseases, have all contributed to changing market dynamics.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/animal-vaccines-market
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Animal Vaccines Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Animal Vaccines Market is segmented by Product, Route of Administration, Animal Type, Distribution Channel, and region.
Based on Product, the market is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines.
Based on Route of Administration, the market is segmented into Subcutaneous, Intramuscular, and Intranasal.
Based on Animal Type, the market is segmented into Livestock, and Companion
Based on Distribution Channel, the market is segmented into Retail, E-Commerce, and Hospital/ Clinic Pharmacy.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Animal Vaccines Market – Regional Analysis:
North America dominated the global Animal Vaccines Market, accounting for more than 27.5% of revenue in 2021. Throughout the forecast period, the region is expected to maintain its dominant position. This large proportion can be attributed to the high prevalence of livestock and zoonotic diseases, which result in mass animal deaths. Furthermore, the large presence of well-established pharmaceutical firms that are consistently striving for broad commercialization of their vaccines and expanding their geographic reach is expected to drive Animal Vaccines Market growth.
The Asia Pacific region is expected to witness fastest growth in the global animal vaccines market. Pet adoption is on the rise, major vaccination players are expanding, product availability is rising, and manufacturing facilities are being invested in across the Asia Pacific, particularly in India, China, and Thailand, boosting market growth.
Top Market Players in Animal Vaccines Market are:
Zoetis
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
Elanco Animal Health Inc.
Bayer AG
Virbac
Ceva
HIPRA
Hester Biosciences Limited
Biogenesis Bago
Vaxxinova
IDT Biologika GmbH
Bimeda Animal Health
BravoVax
MSD Animal Health
Agrovet Market Animal Health
Anicon Labor GmbH
Recent Developments:
In June 2021, Merck Animal Health and Automazioni VX, Inc. have formed a partnership. The primary objective of this partnership was to introduce Innoject Pro, a new subcutaneous chick vaccination technology. The technology will be used in combination with Merck Animal Health’s Innovax vaccines, which are designed to protect poultry from infectious diseases.
In June 2021, The United Kingdom announced the start of a U.K. Animal Vaccine Manufacturing and Innovation Centre in Surrey, to speed up the development of livestock vaccines and control the spread of viral diseases such as coronavirus.
In November 2020, the virtual launch of GUMBOHATCH’s new generation Infectious Bursal Disease immune complex immunization product for broiler chickens was announced by HIPRA Indonesia.
You may Also Like
https://issuu.com/skyquest-technology/docs/global_arcade_gaming_market_size
https://issuu.com/skyquest-technology/docs/men_s_wear_market_forecast_growth_projections_and
Forward-Looking Insights
The Animal Vaccines Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
